Big Plans and 40 Years of Experience
News Jun 30, 2015
Rudi Vollmer (61) has become the new Technical Managing Director of Greiner Bio-One GmbH. Vollmer, formerly head of production at the Frickenhausen site, replaces Rainer Perneker, who has left the management team in Germany to focus on the business as Divisional Manager of the Greiner Bio-One International GmbH.
As a member of the Greiner Bio-One GmbH Germany management team, Rudi Vollmer is now responsible for production and technology. Heinz Schmid stays as head of the sales division and the management spokesperson. Georg Heftberger remains responsible for commercial and business operations. “I have extensive plans for working with the other two Managing Directors to build the success of Greiner Bio-One GmbH in Frickenhausen,” says Vollmer, whose responsibilities also cover the key areas of quality management, project management and design.
Anniversary - total of 40 years with Greiner
Rudi Vollmer started his career at Greiner (Labortechnik) in Nürtingen in 1975 - in the field of toolmaking. In 1978, he qualified and was taken on as a production foreman. He moved to the newly built site in Frickenhausen in 1988, where he took over management of the high-throughput screening and immunology production divisions three years later. When project management was introduced in March 2006, Rudi Vollmer took on full management of production. He celebrated 40 years at the company in April 2015.
Macrophage's Role in Maintaining Tattoos Could Hold Key to RemovalNews
Researchers have discovered that, though a tattoo may be forever, the skin cells that carry the tattoo pigment are not. Instead, the cells can pass on the pigment to new cells when they die. The study suggests ways to improve the ability of laser surgery to remove unwanted tattoos.READ MORE
New Causes of Cellular Decline in Prematurely Aging Kids DiscoveredNews
In a recent paper published in Cell Reports, Saint Louis University researchers have uncovered new answers about why cells rapidly age in children with a rare and fatal disease. The data points to cellular replication stress and a mistaken innate immune response as culprits, and the team found success in the laboratory in blocking these processes with vitamin D.READ MORE
Measuring Neutrophil Motility Could Lead to Accurate Sepsis DiagnosisNews
Mass. General researchers design device that rapidly diagnoses sepsis with more than 95 percent accuracy.READ MORE
Comments | 0 ADD COMMENT
International Conference on Neuroimmunology, Neurological disorders and Neurogenetics
Sep 26 - Sep 27, 2018